Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nat Med. 2022 05; 28(5):934-938.
View in:
PubMed
subject areas
Cost-Benefit Analysis
Humans
Vaccination
Vaccines
authors with profiles
Sarah E. Cobey
Anup Malani